Publications by authors named "Chris Estes"

Claim this Profile
C
Comparison of Benefit-to-Burden Ratios for Stool-Based Colorectal Cancer Screening Tests in the U.S.: A Decision Analytical Modeling Approach.
John B Kisiel, A Mark Fendrick, Derek W Ebner, Michael Dore, Chris Estes

AJPM Focus· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RE: Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategies.
Derek W Ebner, Chris Estes, Paul J Limburg

J Natl Cancer Inst· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategies.
Derek W Ebner, A Mark Fendrick, John B Kisiel, Chris Estes, Vahab Vahdat

J Natl Cancer Inst· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in clinical trial and FDA approval datasets: implications for clinical and policy decision-making for noninvasive colorectal cancer screening tests.
Chyke A Doubeni, Chris Estes, A Mark Fendrick, John B Kisiel, Paul J Limburg

Curr Med Res Opin· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Target Stool DNA and the Fecal Immunochemical Test: A Systematic Review and Meta-Analysis on Test Performances.
Derek W Ebner, Heather A Johnson, Chris Estes, William K Johnson, Rukaiyya S Khan

Am J Prev Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the health and economic impact of pharmacologic therapies for MASLD in the United States.
Carolyn Wallace, Ivane Gamkrelidze, Chris Estes, Homie Razavi, Arun J Sanyal

J Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental impact of colorectal cancer screening with colonoscopy and multi-target stool DNA (mt-sDNA) testing.
Rebecca Alcock, Aasma Shaukat, John B Kisiel, Lyndon V Hernandez, Benjo A Delarmente, Chris Estes

Health Aff Sch· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.
Oguzhan Alagoz, Folasade P May, Chyke A Doubeni, A Mark Fendrick, Vahab Vahdat, Chris Estes

J Natl Cancer Inst· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening.
John B Kisiel, A Mark Fendrick, Derek W Ebner, A Burak Ozbay, Vahab Vahdat, Chris Estes

J Med Econ· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open RT Structures: A Solution for TG-263 Accessibility.
Brian M Anderson, Laura Padilla, Jeffrey M Ryckman, Elizabeth Covington, David S Hong, Chris Estes

Int J Radiat Oncol Biol Phys· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated Average-Risk Colorectal Cancer Screening-Eligible Population in the US.
Derek W Ebner, John B Kisiel, A Mark Fendrick, Chris Estes, Kevin Li

JAMA Netw Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.
Derek Ebner, John Kisiel, Lianne Barnieh, Rishika Sharma, Nathaniel J Smith, Chris Estes

J Med Econ· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Call to Action to Increase Uptake of Follow-Up Colonoscopy After Initial Positive Stool-Based Colorectal Cancer Screening.
A Mark Fendrick, John B Kisiel, Durado Brooks, Vahab Vahdat, Chris Estes

Popul Health Manag· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of treating all hepatitis B-positive individuals in the United States.
Devin Razavi-Shearer, Chris Estes, Ivane Gamkrelidze, Homie Razavi

J Viral Hepat· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of immigration on hepatitis B burden in the United States: a modelling study.
Devin Razavi-Shearer, Ivane Gamkrelidze, Calvin Q Pan, Kathryn Razavi-Shearer, Sarah Blach, Chris Estes

Lancet Reg Health Am· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral hepatitis elimination challenges in low- and middle-income countries-Uzbekistan Hepatitis Elimination Program (UHEP).
Erkin Musabaev, Chris Estes, Shakhlo Sadirova, Shokhista Bakieva, Krestina Brigida

Liver Int· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress.
Sarah Blach, Kimberly A Brown, Robert S Brown, Pierre M Gholam, Norah A Terrault, Chris Estes

J Infect Public Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050.
Mia J Biondi, Chris Estes, Devin Razavi-Shearer, Kanwar Sahdra, Nechama Lipton

CMAJ Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies.
Palak J Trivedi, Christopher L Bowlus, Kidist K Yimam, Homie Razavi, Chris Estes

Clin Gastroenterol Hepatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study.
Ellen Dugan, Sarah Blach, Mia Biondi, Zongzhen Cai, Mindi DePaola, Chris Estes

Lancet Gastroenterol Hepatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.
Mark G Swain, Alnoor Ramji, Keyur Patel, Giada Sebastiani, Abdel Aziz Shaheen, Chris Estes

CMAJ Open· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on global HCV elimination efforts.
Sarah Blach, Loreta A Kondili, Alessio Aghemo, Zongzhen Cai, Ellen Dugan, Chris Estes

J Hepatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply.
Chris Estes, Henry L Y Chan, Rong N Chien, Wan-Long Chuang, James Fung

Aliment Pharmacol Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model.
Mawuena Binka, Naveed Z Janjua, Jason Grebely, Chris Estes, Dena Schanzer

JAMA Netw Open· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling NAFLD disease burden in four Asian regions-2019-2030.
Chris Estes, Henry L Y Chan, Rong N Chien, Wan-Long Chuang, James Fung

Aliment Pharmacol Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis